Akira Kobayashi

This inventor holds 25 USPTO granted patents, plus 4 CIPO patents and 6 EPO patents, primarily in Stem Cell Technology. Top assignees: Kaneka Corporation, Matsushita Electric Industrial Co., Ltd., Foundation for Biomedical Research and Innovation. Active years: 1976-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Kobayashi. Retrieved from https://idiyas.com/inventor/akira-kobayashi-486phcyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 80.0

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 6

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 142(Granted Patents)

Location History:

Kobe, JA (1976)
Settsu, JP (2000 - 2008)
Hyogo, JP (2010 - 2015)
Osaka, JP (1991 - 2017)
Takasago, JP (2013 - 2022)

Company Filing History:

Matsushita Electric Industrial Co., Ltd.

patents

2 out of 17

Foundation for Biomedical Research and Innovation

Hyogo College of Medicine

patents

6. 2 out of 51

National Cerebral and Cardiovascular Center

patents

where one patent can have more than one assignee

Years Active: 1976-2022

Loading Chart...

Areas of Expertise:

Amniotic Mesenchymal Stromal Cells

Cryopreservation

Stem Cell Separation

Blood Component Separation

Cell Culture

Lymphocyte Proliferation Inhibitor

Direct Hemoperfusion

Granulocyte Adsorbent

Image Processing

Flaw Detection

Binarizing Method

Width Measurement

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11389486 - Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent (2022-07-19),

2. 10441611 - Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent (2019-10-15),

3. 9708581 - Stem cell separating material and method of separation (2017-07-18),

4. 9649424 - Blood component separation system and separation material (2017-05-16),

5. 9273275 - Disposable set for cell culture, cell culture device and cell preparation method (2016-03-01),

6. 9057052 - Stem cell separating material and method of separation (2015-06-16),

7. 8932854 - Adsorbent for lymphocyte proliferation inhibitor and treating method (2015-01-13),

8. D705443 - Bag for collecting cells (2014-05-20),

9. D686338 - Vessel for culture (2013-07-16),

10. 8357522 - Separating material and method for collecting cell or the like using the same (2013-01-22),

11. 8272518 - Direct hemoperfusion adsorber packed with adsorbent having water insoluble microparticle removed therefrom, and method of obtaining direct hemoperfusion adsorbent having water insoluble microparticle removed therefrom (2012-09-25),

12. 7850858 - Granulocyte adsorbent (2010-12-14),

13. 7320757 - Body fluid processor enabling direct hemoperfusion (2008-01-22),

14. 6697514 - Apparatus for inspecting a fluorescent substance on a plasma display (2004-02-24),

15. 6337368 - Lipoprotein adsorbent and lipoprotein adsorber made with the use of the same (2002-01-08),

Title: **Akira Kobayashi: Innovator in Mesenchymal Stem Cell Research**

Introduction

Akira Kobayashi is a prominent inventor based in Takasago, Japan, known for his significant contributions to the field of biotechnology. With a portfolio consisting of 25 patents, Kobayashi has focused much of his research on advancing methods related to mesenchymal stem cells, particularly those derived from amniotic sources.

Latest Patents

His latest patents include innovative methodologies for producing amniotic mesenchymal stromal cell compositions and techniques for cryopreservation. One notable invention aims to aseptically separate high-purity amnion-derived mesenchymal stem cells (MSCs) through a single enzyme treatment. This method employs collagenase and thermolysin and/or dispase, followed by filtering the treated amnion through a mesh. Furthermore, these advancements culminate in a therapeutic agent composed of the mesenchymal stromal cell composition, which targets diseases such as graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, and radiation enteritis.

Career Highlights

Throughout his career, Akira Kobayashi has worked with notable companies including Kaneka Corporation and Matsushita Electric Industrial Co., Ltd. His expertise and dedication to research have significantly influenced the development of innovative therapies and methodologies in the biomedical field.

Collaborations

Collaborating with esteemed colleagues such as Masaru Nakatani and Shinya Yoshida, Kobayashi has fostered a dynamic research environment that encourages the exchange of ideas and knowledge among experts. Together, they have aimed to push the boundaries of stem cell research and its applications.

Conclusion

Akira Kobayashi's extensive work and inventions in the field of mesenchymal stem cells have positioned him as a key figure in biotechnological innovation. His dedication to advancing medical treatments holds promise for addressing complex diseases, making his contributions invaluable to both the scientific community and society at large.

Profile summary based on public USPTO records.